ModelEdge
20/20 GeneSystems, Inc.
0001139685
Filing type
10-K
Filing date
Mar 30, 2026
Updated
Mar 31, 2026 ยท 3:26 PM

Filing

10-KFY 2025

Exhibits

EX-3.4CERTIFICATE OF DESIGNATION OF SERIES E CONVERTIBLE PREFERRED STOCK OF 20/20 BIOLABS, INCEX-4.1DESCRIPTION OF SECURITIES OF 20/20 BIOLABS, INCEX-4.2WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO STREETERVILLE CAPITAL, LLC ON FEBRUARY 19, 2026EX-4.3WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO MAXIM PARTNERS LLC ON FEBRUARY 19, 2026EX-4.4WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO STREETERVILLE CAPITAL, LLC ON FEBRUARY 9, 2026EX-4.5WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO MAXIM PARTNERS LLC ON FEBRUARY 9, 2026EX-4.7WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED BY 20/20 BIOLABS, INC. TO MAXIM PARTNERS LLC ON NOVEMBER 17, 2025EX-10.2SECURED CONVERTIBLE PROMISSORY NOTE ISSUED BY 20/20 BIOLABS, INC. TO STREETERVILLE CAPITAL, LLC ON FEBRUARY 9, 2026EX-14.1CODE OF BUSINESS CONDUCT AND ETHICSEX-19.1INSIDER TRADING POLICYEX-31.1CERTIFICATIONEX-31.2CERTIFICATIONEX-32.1CERTIFICATIONEX-32.2CERTIFICATIONEX-97.1CLAWBACK POLICYGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic